Literature DB >> 30824461

Neuroleptic malignant syndrome as part of an akinetic crisis associated with sepsis in a patient with Lewy body disease.

Saki Manabe1, Hidetaka Yanagi1, Hideki Ozawa1, Atsushi Takagi1.   

Abstract

A 65-year-old Japanese woman with Parkinson's disease, later diagnosed with Lewy body disease, presented with a 2-day history of systemic tremors. She also had fever without rigidity or creatine kinase (CK) elevation. She was diagnosed with sepsis caused by pyelonephritis with acute kidney injury and parkinsonism exacerbation. Although antibiotic and fluid therapy improved her pyuria and renal function, her fever and tremors persisted. On the fourth day, her symptoms worsened and resulted in cardiopulmonary arrest; however, quick resuscitation allowed the return of spontaneous circulation. Simultaneously, hyperthermia, altered consciousness, extrapyramidal symptoms, dysautonomia and CK elevation were noted. Thus, dantrolene administration was initiated with a tentative diagnosis of neuroleptic malignant syndrome (NMS). This caused her fever to subside, and her symptoms gradually improved. It was difficult to distinguish between parkinsonism exacerbation associated with sepsis and NMS. Physicians should consider NMS early on, even if the patient does not fulfil the diagnostic criteria. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  intensive care; neurology; primary care; psychiatry; unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2019        PMID: 30824461      PMCID: PMC6398821          DOI: 10.1136/bcr-2018-227216

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

Review 1.  Neuroleptic malignant syndrome.

Authors:  Jeffrey R Strawn; Paul E Keck; Stanley N Caroff
Journal:  Am J Psychiatry       Date:  2007-06       Impact factor: 18.112

Review 2.  [Drug-induced neuroleptic malignant syndrome].

Authors:  Hiroaki Jitsuiki; Hidehisa Yamashita; Toshiro Kozuru; Shigeto Yamawaki
Journal:  Nihon Naika Gakkai Zasshi       Date:  2007-08-10

Review 3.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

4.  Acute akinesia in Parkinson disease.

Authors:  Marco Onofrj; Astrid Thomas
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

5.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

Authors:  I McKeith; T Del Ser; P Spano; M Emre; K Wesnes; R Anand; A Cicin-Sain; R Ferrara; R Spiegel
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

Review 6.  Serotonin syndrome. A clinical update.

Authors:  K C Mills
Journal:  Crit Care Clin       Date:  1997-10       Impact factor: 3.598

7.  A collaborative study on the malignant syndrome in Parkinson's disease and related disorders.

Authors:  Hideki Takubo; Toshihide Harada; Takao Hashimoto; Yutaka Inaba; Ichiro Kanazawa; Sadako Kuno; Yoshikuni Mizuno; Eiji Mizuta; Miho Murata; Toshiharu Nagatsu; Shigenobu Nakamura; Nobuo Yanagisawa; Hirotaro Narabayashi
Journal:  Parkinsonism Relat Disord       Date:  2003-04       Impact factor: 4.891

Review 8.  Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment.

Authors:  Marco Onofrj; Laura Bonanni; Giovanni Cossu; Davide Manca; Fabrizio Stocchi; Astrid Thomas
Journal:  Parkinsonism Relat Disord       Date:  2009-12       Impact factor: 4.891

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Elevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: a report of two cases.

Authors:  Koichi Nisijima
Journal:  Neuropsychiatr Dis Treat       Date:  2012-12-13       Impact factor: 2.570

View more
  1 in total

1.  Dubito Ergo Sum. Pathologies that can Mimic Sepsis.

Authors:  Bianca-Liana Grigorescu
Journal:  J Crit Care Med (Targu Mures)       Date:  2022-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.